Ella Jeffries / beckershospitalreview - AbbVie has filed a lawsuit challenging federal guidance on how “patient” is defined under the 340B program, according to an April 8 press release. The company said the current definition, based on guidance issued in 1996, allows covered entities to claim …
AI Summary: AbbVie has filed suit challenging HHS’s interpretation of the 340B program, arguing the agency’s “patient” definition and related guidance are outdated and legally flawed. The company seeks judicial clarity that could reshape who qualifies for discounted drugs and how hospitals and manufacturers navigate the program — yes, the pricing drama continues.
340B discounts face reform as profits outpace patient benefit / 5 wks
Bill would let patient drug spending count toward insurance deductibles / 6 wks
Hospitals push regulators to block expanded 340B claims reporting requirements / 2 months
131 hospitals sue HHS over alleged Disproportionate Share underpayments / 1 month
Senate Democrats unveil plan to cut health costs and expand coverage / 2 months
Optum Rx/Caremark and FTC edge toward settlement in insulin case / 2 months
Nearly 10% of surgeons exit clinical practice within eight years / 8 days
StackHealth RSS

StackHealth Time Machine
NorthFeed Inc. Terms and Conditions / Privacy Policy
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.